From Pursued to Partner! Possible Mega-Deal with Novo Nordisk Ignites Stock Fireworks at Hims & Hers!

After massive pressure from US authorities and impending patent lawsuits, the lucrative business of weight loss products at Hims & Hers (HIMS) was on the brink. But now, things are taking a dramatic turn. Rumors of a spectacular distribution partnership with former rival Novo Nordisk propelled the stock premarket by almost 45% and could instantly make the struggling telemedicine company the official winner in the fiercely competitive billion-dollar weight loss market. From Bitter Rival to Lucrative Partner The emerging telemedicine company...